Keywords
COVID-19
Coronavirus Infection
Male Sexual Health
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To investigate the relationship between erectile dysfunction (ED) and COVID-19 by examining relevant studies. Methods: This is an integrative review regarding the relationship between erectile dysfunction (ED) and COVID-19 conducted between the years 2021 and 2024, using the LILACS and MEDLINE databases, the Health Sciences Descriptors (DeCS) "Erectile Dysfunction," "Infection," and "COVID-19." Results: 13 articles were selected for analysis. The reviewed studies provide evidence of a significant association between COVID-19 and erectile dysfunction, damage to the cavernous smooth muscle, increasing the prevalence of erectile dysfunction even after mild infections, endothelial dysfunction, psychological burden, and decreased hormone levels induced by COVID-19. Final considerations: The relationship between COVID-19 and erectile dysfunction is complex and multifactorial, involving hormonal, psychological, and vascular factors, as well as risk, factors and the underlying mechanisms. Early diagnosis, analysis of environmental factors and post-infection psychological support are essential to mitigate adverse effects on male sexual function.
References
ABEDINZADEH M, et al. Effect of COVID-19 On the Sexual Activity of Men. American Journal of Men's Health, 2023; 17(4): 15579883231193913.
ADEYEMI DH, et al. Impact of COVID 19 on erectile function. The aging male: the official journal of the International Society for the Study of the Aging Male, 2022; 25(1): 202–216.
AL-KURAISHY HM. et al. Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19. Scientific Reports, 2023; 13(1): 5977.
ALGRANTI E, et al. Prevenção à COVID-19: orientações para prevenção e controle da COVID 19 nos locais de trabalho. Fundacentro, 2020: 32.
BRUNO ZV e REIS PHM. O impacto do tratamento da disfunção erétil sobre o casal. Revista Brasileira De Sexualidade Humana, 2020; 18(1).
COUTINHO PJR, et al. Caracterização e aspectos psicológicos de pacientes com disfunção erétil. Revista Psicologia: Teoria e Prática, 2020; 22(3): 321-355.
EPAMINONDAS WA, et al. Estudo da prevalência de disfunção erétil em ambulatório de Urologia no sistema único de saúde do Distrito Federal. Brasília Med, 2022; 59: 1-12.
GODOI ALD e FACIO JUNIOR FN. Prescrição, oferta e acesso aos medicamentos para disfunção erétil: um paradoxo na saúde pública? Ciência & Saúde Coletiva, 2024; 29: e17702022.
KARKIN K e ALMA E. Erectile dysfunction and testosterone levels prior to COVID-19 disease: what is the relationship? Archivio Italiano di Urologia e Andrologia, 2021; 93(4): 460-464.
KATZ J, et al. Increased odds ratio for erectile dysfunction in COVID-19 patients. Journal of Endocrinological Investigation, 2022; 45(4): 859-864.
KAYNAR M, et al. Tip of the iceberg: erectile dysfunction and COVID-19. International Journal of Impotence Research, 2022; 34(2): 152-157.
KRESCH E, et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. The world journal of men's health, 2021; 39(3): 466.
LIMA EG, et al. Estudo comparativo de eficácia e segurança da Sildenafila e Tadafila no tratamento da disfunção erétil: Revisão Sistemática. Brazilian Journal of Health Review, 2021; 4(6): 26269-26282.
PASINI E, et al. Serum Metabolic Profile in Patients With Long-Covid (PASC) Syndrome: Clinical Implications. Front Med, 2021; 22(8):714426.
SALAR R, et al. Effect of COVID‐19 infection on the erectile function. Andrology, 2023; 11(1): 10-16.
SANSONE A, et al. Addressing male sexual and reproductive health in the wake of COVID-19 outbreak. Journal of endocrinological investigation, 2021; 44(2): 223-231.
SIVRITEPE R, et al. The effect of interleukin‐6 level at the time of hospitalisation on erectile functions in hospitalised patients with COVID‐19. Andrologia, 2022; 54(1): e14285.
SONG WJ, et al. The impact of the COVID-19 pandemic on erectile function in Chinese CP/CPPS patients. Asian journal of andrology, 2023; 25(6): 680-686.
UNAL S, et al. A Possible Mechanism of Erectile Dysfunction in Coronavirus Disease-19: Cavernosal Smooth Muscle Damage: A Pilot Study. Revista Internacional de Andrología, 2023.
ZHANG J, et al. Prevalence and risk factors of erectile dysfunction in COVID-19 patients: a systematic review and meta-analysis. Journal of endocrinological investigation, 2023; 46(4): 795-804, 2023.
ZHANG K, et al. Genetic susceptibility to COVID‐19 may increase the risk of erectile dysfunction: A two‐sample Mendelian randomization study. Andrologia, 2022; 54(10): e14527.
JOSE RJ e MANUEL A. COVID-19 cytokine storm: the interplay between inflammation and coagulation. Lancet Respir Med., 2020; 8: e46-e47.
Buselli R, Corsi M, Baldanzi S, Chiumiento M, Del Lupo E, Dell'Oste V, et al. Qualidade de vida profissional e resultados de saúde mental entre profissionais de saúde expostos ao Sars-Cov-2 (Covid-19) Int J Environ Res Public Health. 2020; 17 (17):6180.
MENTER T, et al. Postmortem examina-tion of COVID-19 patients reveals diffuse alveolar damage withsevere capillary congestion and variegated findings in lungs and otherorgans suggesting vascular dysfunction. Histopathology. 2020;77:198-209.